Yang Mao‐Draayer

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients

Qi Wu, Qin Wang, Guangmei Mao et al. · The Journal of Immunology · 2017 · 176 citations · Full text

Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment

Fanny Huynh Du, Elizabeth Mills, Yang Mao‐Draayer · Autoimmunity Highlights · 2017 · 174 citations · Full text

Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation

Jeongho Park, Qin Wang, Qi Wu et al. · Scientific Reports · 2019 · 169 citations · Full text

Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway

Qin Wang, Sergei Chuikov, Sophina H. Taitano et al. · International Journal of Molecular Sciences · 2015 · 125 citations · Full text

Neurological Progress, Cell Death, Oxidative Stress +21